Join us on March 7 for our Educated Patient Summit on Breast Cancer taking place in Miami, FL! 

To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Sherry B. Hanson
One cancer survivor details how her immunotherapy changed her cancer journey for the better, and how ongoing trials of immunotherapy are looking to change the cancer landscape for the better.
Nagashree Seetharamu, MD, MBBS
Immunotherapy in combination with chemotherapy is becoming a popular treatment for patients with lung cancer, but patients need to understand the side effects.
Kristie L. Kahl
A nurse practitioner explains why it is key for patients with lung cancer being treated with immunotherapy to be aware of the treatment’s potential side effects.
Dr. Hossein Borghaei
Hossein Borghaei, DO, MS, of Fox Chase Cancer Center, discusses emerging treatment options for patients with lung cancer.
Andrew D. Smith
Using artificial intelligence to analyze huge stores of information known as big data boosts the effectiveness of cancer diagnosis and treatment.
Kristie L. Kahl
A blood test may help to identify the best treatment option for patients with ALK-positive, advanced non-small cell lung cancer, sparing patients from having to undergo an invasive biopsy.
Katie Kosko and Brielle Benyon
Here’s a look at what’s inside our 2019 Immunotherapy special issue.
Nicholas Howe
An early clinical trial participant likens his journey into the unknown to a space mission.
Katie Kosko
A man who received chimeric antigen receptor-T cell therapy shares his firsthand account.
Debu Tripathy, M.D.
Although there is much to learn about the intricacies of how the immune system interacts with cancer, advances are occurring rapidly as immunotherapy for cancer has exploded with myriad ongoing clinical trials and newer drugs coming on line constantly.

Sign In

Not a member? Sign up now!
Continue without login